GlobeNewswire by notified

JLT Mobile Computers strengthens brand presence at LogiMAT 2022 with showcase of ultra-reliable forklift computers for Windows and Android


Visit JLT Mobile Computers at LogiMAT 2022,
Hall 8/Booth A15, 31 May-2 June 2022, Stuttgart, Germany

To view this piece of content from, please give your consent at the top of this page.

Image available:

Caption: JLT customer Freshvaluesthe fixed-mount JLT6012 forklift computers for their ability to withstand even the roughestwarehouse floor conditionsso that operations can keep running smoothly.

JLT Mobile Computers strengthens brand presence atLogiMAT2022with showcase of ultra-reliable forklift computers for Windows and Android

One-stop-shop provider of rugged Android and Windows fixed-mount and portablecomputers, software, accessories, and services embraces live return of Germany’s landmark logistics event as an opportunity to make its mark under its own logo.

Växjö, Sweden, 21April2022  * * *  JLTMobile Computers, a leading developer of reliable computing solutions for demanding environments, welcomes the live return of LogiMAT 2022 by strengthening its brand presence at Germany’s key logistics show. For the first time, JLT will be presenting its extensive portfolio of high-end vehicle-mount and portable Android and Windows computers, software, accessories, and services under its own JLT logo (Hall8/Booth A15). As with previous years, JLT’s products will also be on display at the stand of its local partner ecovium (Hall 8/Booth D61).

Symbolic of JLT’s rapid recovery from the Covid pandemic, the expanded LogiMAT presence underlines the company’s aim to continue its growth path by strengthening its sales, partner and customer support channels across the important and quality-driven central European market.

I think I speak for the entire industry when I say how great it is to see LogiMAT return as a live event this year,” says Per Holmberg, CEO of JLT Mobile Computers Group. “The show has long been a significant date on JLT’s annual events calendar and an important platform to presentour rugged devices to the industry through our regional partner network.I am immensely proud that this year we are taking our engagement to the next levelwith a direct JLT presence to showcase our high-quality product and service offeringthat makes a perfect fit for this quality-conscious market.

Committed to excellence in everything it does, JLT develops and manufactures rugged mobile computers to the highest quality standards in its Swedish facilities. The company applies the same quality principles to its growing network of carefully selected and thoroughly evaluated local sales partners. As a one-stop-shop rugged IT solutions provider with 25+ years of experience in supporting device deployment and lifecycle management, JLT addresses the full breadth of logistics customers’ needs while continuing to focus on its unique specialty: Fixed-mount forklift computers that ensure ultimate reliability and durability in the harshest logistics environments.

An example of JLT’s fully rugged forklift PCs, and a highlight at the LogiMAT booth (A15, Hall 8), is the acclaimed JLT6012 Series of vehicle-mount logistics computers. Besides the popular Windows version (JLT6012™), the Series now also comprises the well-received new Android 10 based JLT6012A™ terminal (see professional review), which addresses the rapidly increasing demand for the Android operating system in material handling, logistics and supply chain operations. Equipped with unparalleled functionality, the JLT6012 Series presents a flexible platform for developing innovative hardware, software and services for the needs of today and tomorrow. Processing and wireless connectivity performance are outstanding, maintenance costs minimal, wear and tear prone components easily serviced, and the growing number of software features, many of which are developed in-house by JLT’s dedicated software branch, can be upgraded remotely.

What is more, despite their industrial-grade ruggedness, the JLT6012 forklift computers come in a modern look and feel, with a user-friendly interface that meets the aesthetic expectations of today’s workforce. For larger business cases, the Series can also be customized for specific operational requirements following thorough on-site evaluation.

Customers across Europe – from Nordic ventilation system supplier Fresh to global steel company SSAB – value the unique ruggedness of the JLT6012 series to sustain reliable operation in less-than-optimal conditions.

At SSAB we pride ourselves in our commitment to not only performance but also sustainability,” says Klas Lundåsen, IT Technician at SSAB Common IT Service. “That goes for our specialized products and services, and it also goes for third party products we use in our organization. Our relationship with JLT started in 2003 and their products have been up and running with an almost non-existent failure rate ever since then. The latest addition JLT6012 computers fit right in; they’re built to last.”

To learn more about JLT and why customers all over the world rely on our rugged hardware, software and services, visit, or go here to book a meeting with Danny Dierckx, European Channel & Solution Director, at the JLT booth A15 in Hall 8 during LogiMAT 2022 in Stuttgart.

Reader Enquiries
JLT Mobile Computers Group JLT Mobile Computers
Per Holmberg, CEO Danny Dierckx, European
Tel.: +46 70 361 3934 Channel & Solution Director
Press ContactCertified Adviser
PRismaPR Eminova Fondkommission AB
Monika Cunnington Tel.: +46 08 684 211 10
Tel.: +44 20 8133 6148

About JLT Mobile Computers

Reliable performance, less hassle. JLT Mobile Computers is a leading supplier of rugged mobile computing devices and solutions for demanding environments. Over 25 years of development and manufacturing experience have enabled us to set the standard in rugged computing, combining outstanding product quality with expert service, support, and solutions to ensure trouble-free business operations for customers in warehousing, transportation, manufacturing, mining, ports, and agriculture. JLT operates globally from offices in Sweden, France, and the US, complemented by an extensive network of sales partners in local markets. The company was founded in 1994, and the share has been listed on the Nasdaq First North Growth Market stock exchange since 2002 under the symbol JLT. Eminova Fondkommission AB acts as Certified Adviser. Learn more at


To view this piece of content from, please give your consent at the top of this page.
To view this piece of content from, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

ERYTECH to Present at the H.C. Wainwright Global Investment Conference17.5.2022 22:05:00 CEST | Press release

ERYTECHtoPresent at the H.C. WainwrightGlobal Investment Conference Cambridge, MA (U.S.) and Lyon (France), May 17, 2022 – ERYTECH Pharma (Nasdaq & Euronext: ERYP), a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating therapeutic drug substances inside red blood cells, today announced that its Chief Executive Officer, Gil Beyen, will present at the H.C. Wainwright Global Investment Conference. The conference will be held in a hybrid format from May 23-26, 2022, in Miami, USA. The corporate presentation will be held in person on Wednesday, May 25 at 10:30am ET and will be available on-line on the conference website afterwards. Mr. Beyen will be available for one-to-one meetings with investors on May 24, 25 and 26. If you would like to arrange a one-on-one meeting or register, please contact your conference representative. For more information on the H.C. Wainwright 23rd Global Investment Conference, please visit the H.C. Wainwright Conference websi


Publication on May17, 2022, after market closure Regulated information EVS Broadcast Equipment S.A.: Euronext Brussels (EVS.BR), Bloomberg (EVS BB), Reuters (EVSB.BR) EVSCOMMUNICATES THERESULTSOFTHEORDINARYGENERAL MEETING EVS Broadcast Equipment SA, leading provider of live video production systems, held its Ordinary General Meeting on May 17, 2022. In total 73 shareholders representing 2,799,870 shares, or 19.5% of the company shares, attended by proxy the Ordinary General Meeting held physically at the company's registered office but for which the company had recommended its shareholders to attend by videoconference given the still sensitive health situation. All the resolutions have been approved, i.e.: - The remuneration report, the updated remuneration policy, the discharge of the Directors and the Auditor; - The 2021 annual accounts and the allocation of profits, including a total gross dividend of EUR 1.50 for fiscal year 2021 (such dividend is made up, on the one hand, of the i

SeaLegacy Celebrates the Inaugural Year of The Good Ocean17.5.2022 21:49:59 CEST | Press release

A unified, passionate group of businesses investing in SeaLegacy’s mission to protect the world’s oceans British Columbia, Canada, May 17, 2022 (GLOBE NEWSWIRE) -- When eight companies mostly unknown to one another came together for the first time in May of 2021, they were bound only by a commitment to protect our oceans and planet. Today, these founding members of The Good Ocean are actively supporting SeaLegacy’s commitment to ocean protection. "One of the questions I get asked the most is, 'What can I do?'" says SeaLegacy Co-Founder and President Cristina Mittermeier. "This question comes from individuals, and it also comes from businesses. Increasingly, consumers are demanding the products and services they support with their purchasing power be aligned with their desire to be accountable for their impact on earth. Members of The Good Ocean are addressing that demand and stepping into the crucial role businesses play in conservation work. Together, we are taking steps towards syste

Karolinska Development’s portfolio company Aprea Therapeutics acquires Atrin Pharmaceuticals17.5.2022 16:55:38 CEST | Press release

STOCKHOLM, SWEDEN, May 17 2022. Karolinska Development AB (Nasdaq Stockholm: KDEV) announces that its portfolio company Aprea Therapeutics has completed the acquisition of the privately-held US-based biotechnology company Atrin Pharmaceuticals Inc. Aprea Therapeutics will now prioritize the development of Atrin Pharmaceuticals’ drug candidates, which are being developed to fight cancer by affecting the proteins involved in the ability of tumors to repair damage to their DNA. With the acquisition of Atrin Pharmaceuticals’ portfolio of candidate drugs, Aprea Therapeutics intends to shift its primary focus to the development of ATRN-119, a drug candidate that inhibits an important signaling pathway in DNA damage repair. ATRN-119 will soon be evaluated in clinical phase 1/2a studies in the treatment of malignant solid tumors, both as monotherapy and in combination with standard treatment. In parallel with the development of ATRN-119, separate programs are run with a second-generation ATR i

Karolinska Developments portföljbolag Aprea Therapeutics förvärvar Atrin Pharmaceuticals17.5.2022 16:55:38 CEST | Pressemelding

STOCKHOLM, SVERIGE 17 maj 2022. Karolinska Development AB (Nasdaq Stockholm: KDEV) meddelar idag att portföljbolaget Aprea Therapeutics har förvärvat det privatägda amerikanska bioteknikbolaget Atrin Pharmaceuticals Inc. Aprea Therapeutics kommer nu att prioritera utvecklingen av Atrin Pharmaceuticals läkemedelskandidater, vilka utvecklas för att bekämpa cancersjukdomar genom att påverka de proteiner som är involverade i tumörers förmåga att reparera skador i sitt DNA. Efter förvärvet av Atrin Pharmaceuticals läkemedelsprojekt flyttar Aprea Therapeutics sitt primära fokus till utvecklingen av ATRN-119, en läkemedelskandidat som hämmar en viktig signaleringsväg vid reparation av DNA-skador. ATRN-119 kommer inom kort att börja studeras i kliniska fas 1/2a-studier vid behandling av maligna solida tumörer, både som monoterapi och i kombination med standardbehandling. Parallellt med utvecklingen av ATRN-119 bedrivs separata program med en andra generationens ATR-hämmare, ATRN-354, med poten